Around two thirds of medicines that have been through the AMNOG pricing process have undergone at least two price reductions on the freely-set launch price. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
